With a second late-stage trial win for its investigational HIV combo in the books, Gilead Sciences is moving full steam ahead toward regulatory filings for the novel HIV regimen. In Gilead's ...

Add Yahoo as a preferred source to see more of our stories on Google. Logos of Gilead at the company’s booth at the 8th China International Import Expo (CIIE) in Shanghai, China, November 6, ...

BUFFALO, N.Y. (WKBW) — The African American Cultural Center on Masten Avenue unveiled its first major renovation in decades during a joyful celebration filled with dancing and community pride. The $1 ...

Sujata Tewari, BA, previously of the Medical Practice Evaluation Center (MPEC) at Massachusetts General Hospital, and Andrea L. Ciaranello, MD, MPH, of the MPEC and Department of Medicine at ...

UCSF researchers say they have found a treatment for HIV that shows potential as a long-term solution for the chronic disease that up until this point has been held at bay in patients through the use ...

A 60-year-old man based in Berlin, Germany, has become the seventh known person in the world to achieve long-term HIV remission, thanks to undergoing cancer treatment for his leukemia. The patient had ...

Researchers led by a team from Mass General Brigham and the Ragon Institute have discovered why some people living with HIV who are given a treatment called broadly neutralizing anti-HIV antibodies ...

People infected with HIV must take antiretroviral drugs for life. But engineered antibodies appeared to suppress the virus for certain participants in recent trials in Africa and Europe A digital ...

A new study from UC San Francisco shows it may be possible to control HIV without long-term antiviral treatment - an advance that points the way toward a possible cure for a disease that affects 40 ...

Use of lenacapavir in people with HIV who are heavily treatment-experienced resulted in high levels of virologic suppression, according to two small studies presented at the Infectious Disease Week ...

Nov 19 (Reuters) - Merck (MRK.N), opens new tab said on Wednesday its experimental oral HIV medicine was found to be non-inferior to Gilead Sciences' (GILD.O), opens new tab top-selling drug Biktarvy ...

HARARE, Zimbabwe (AP) — Eswatini on Tuesday became the first African country to receive lenacapavir, the first twice-yearly HIV prevention injection hailed by global health officials as a game-changer ...